Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Entertainment Press.
Press releases published on August 29, 2025
ZyDoc Showcases Breakthrough EHR Documentation Technology at EURETINA 2025 in Paris; Seeking European Pilot Partners
ZyDoc joins EURETINA 2025 in Paris to showcase its groundbreaking AI + human-verified EHR tech and explore new European markets with pilot partners. PARIS, FRANCE, August 29, 2025 /EINPresswire.com/ -- ZyDoc, the next-generation leader in clinical …
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address root causes of ITP Approval based on LUNA 3 phase 3 study that demonstrated rapid and durable …
BCS Travel B.V. Secures European Union Trademark Protection for Charter Transport Brand "BCS YOUR CHARTER EXPERT"
Amsterdam-based transport company receives official EUIPO trademark registration #018024837, covering charter services across 27 EU states. AMSTERDAM, NETHERLANDS, August 29, 2025 /EINPresswire.com/ -- BCS Travel B.V., a leading charter and passenger …
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM Nantes, August 29, 2025, 8:00 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today published a comprehensive …
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale NANTES, France - 29 août 2025, 8h00 CET – OSE Immunotherapeutics SA (ISIN: …